scholarly journals A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States

2020 ◽  
Vol 22 ◽  
pp. 100350 ◽  
Author(s):  
Robert S Levine ◽  
Maria C Mejia ◽  
Jason L Salemi ◽  
Sandra J Gonzalez ◽  
Muktar H Aliyu ◽  
...  
2006 ◽  
Vol 131 (2) ◽  
pp. 478-484 ◽  
Author(s):  
Omana V. Nainan ◽  
Miriam J. Alter ◽  
Deanna Kruszon-Moran ◽  
Feng-Xiang Gao ◽  
Guoliang Xia ◽  
...  

2021 ◽  
pp. 003335492110472
Author(s):  
Hope King ◽  
J. E. Soh ◽  
William W. Thompson ◽  
Jessica Rogers Brown ◽  
Karina Rapposelli ◽  
...  

Objective Approximately 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. The objective of our study was to describe demographic and socioeconomic characteristics, liver disease–related risk factors, and modifiable health behaviors associated with self-reported testing for HCV infection among adults. Methods Using data on adult respondents aged ≥18 from the 2013-2017 National Health Interview Survey, we summarized descriptive data on sociodemographic characteristics and liver disease–related risk factors and stratified data by educational attainment. We used weighted logistic regression to examine predictors of HCV testing. Results During the study period, 11.7% (95% CI, 11.5%-12.0%) of adults reported ever being tested for HCV infection. Testing was higher in 2017 than in 2013 (adjusted odds ratio [aOR] = 1.27; 95% CI, 1.18-1.36). Adults with ≥some college were significantly more likely to report being tested (aOR = 1.60; 95% CI, 1.52-1.69) than adults with ≤high school education. Among adults with ≤high school education (but not adults with ≥some college), those who did not have health insurance were less likely than those with private health insurance (aOR = 0.78; 95% CI, 0.68-0.89) to get tested, and non–US-born adults were less likely than US-born adults to get tested (aOR = 0.77; 95% CI, 0.68-0.87). Conclusions Rates of self-reported HCV testing increased from 2013 to 2017, but testing rates remained low. Demographic characteristics, health behaviors, and liver disease–related risk factors may affect HCV testing rates among adults. HCV testing must increase to achieve hepatitis C elimination targets.


Hepatology ◽  
2018 ◽  
Vol 69 (3) ◽  
pp. 1020-1031 ◽  
Author(s):  
Megan G. Hofmeister ◽  
Elizabeth M. Rosenthal ◽  
Laurie K. Barker ◽  
Eli S. Rosenberg ◽  
Meredith A. Barranco ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document